Article Listing - 3M's Aldara delayed for skin cancer

HUNGARIAN DRUGS "STILL COMPETITIVE"

6 April 1992

Despite the collapse of the Soviet market, Hungarian pharmaceutical companies have succeeded in making up for these lost sales by...

PROFITS UP AT ITALIAN SORIN BIOMEDICA IN 1991

6 April 1992

Sorin Biomedica made net profits in 1991 of 12.3 billion lire ($9.9 billion), up from 11 billion lire in the...

EPIC REGISTRATION NOW OVER 1,300

6 April 1992

Speaking at the 12th International Symposium on Intensive Care and Emergency Medicine in Brussels, late last month, Andre Heyns, Roussel-...

INTERFERON ALFA-N3 AND AIDS

6 April 1992

Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...

PA CONSULTING GROUP APPOINTMENTS

6 April 1992

Appointed as senior associates for the pharmaceutical industry at PA Consulting Group are Keith Mansford, former chairman of R&D...

ICN HUBBER GROUP IN SPAIN

6 April 1992

The ICN Hubber Group is investing 1.7 billion pesetas ($2.2 million) in a new pharmaceutical plant near Barcelona in Spain....

US FDA USER FEES: "THE TIME HAS COME"

6 April 1992

People in the US Food and Drug Administration-regulated industries now recognize that the time has arrived for user fees to...

WORLD MARKET FOR BIO-DRUGS

6 April 1992

Biopharmaceuticals will be the single fastest-growing segment of the total pharmaceutical market worldwide in the 1990s, with average annual growth...

TAMOXIFEN OF BENEFIT IN OSTEOPOROSIS?

6 April 1992

A US study looking at the effects of Imperial Chemical Industries' synthetic anti-estrogen Nolvadex (tamoxifen) in post-menopausal women with early-stage...

DRUGS AND SWEDEN'S HEALTH BILL

6 April 1992

Sales of pharmaceutical products in Sweden totaled 10 billion krone ($1.6 billion) in 1990, an increase of 1 billion krone...

Showing 94611-94620 of 95582 articles